Strength
180 mg/1
Manufacturer
Oceanside PharmaceuticalsNDC
68682030130
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
PYRIDOSTIGMINE BROMIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA011665On Market Since
1/12/1959
Pharmacological Classes
Cholinesterase Inhibitor
Cholinesterase Inhibitors
Related Drugs
Same classification
DONEPEZIL HCL 5 MG TABLET
Generic
00904647761•Major Pharmaceuticals
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
13668010210•Torrent Pharmaceuticals Limited
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
13668010230•Torrent Pharmaceuticals Limited
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
13668010290•Torrent Pharmaceuticals Limited
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077803•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077809•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077810•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
16571077850•Rising Pharma Holdings Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
31722073705•Camber Pharmaceuticals Inc.
$0.0440
per EA
DONEPEZIL HCL 5 MG TABLET
Generic
31722073730•Camber Pharmaceuticals Inc.
$0.0440
per EA